Cargando…
Activation of 2,4-Diaminoquinazoline in Mycobacterium tuberculosis by Rv3161c, a Putative Dioxygenase
The diaminoquinazoline series has good potency against Mycobacterium tuberculosis. Resistant isolates have mutations in Rv3161c, a putative dioxygenase. We carried out metabolite analysis on a wild-type strain and an Rv3161c mutant strain after exposure to a diaminoquinazoline. The parental compound...
Autores principales: | Melief, Eduard, Bonnett, Shilah A., Zuniga, Edison S., Parish, Tanya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325208/ https://www.ncbi.nlm.nih.gov/pubmed/30323042 http://dx.doi.org/10.1128/AAC.01505-18 |
Ejemplares similares
-
Deletion of Rv2571c Confers Resistance to Arylamide Compounds in Mycobacterium tuberculosis
por: Shelton, Catherine D., et al.
Publicado: (2021) -
In Vitro Isolation and Characterization of Oxazolidinone-Resistant Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2017) -
Triazolopyrimidines Target Aerobic Respiration in Mycobacterium tuberculosis
por: Shelton, Catherine, et al.
Publicado: (2022) -
A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis
In Vitro
por: Patel, Nipul, et al.
Publicado: (2017) -
Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis
por: Modlin, Samuel J., et al.
Publicado: (2021)